Expert opinion on NSCLC small specimen biomarker testing — Part 1: Tissue collection and management

Biomarker testing is crucial for treatment selection in advanced non-small cell lung cancer (NSCLC). However, the quantity of available tissue often presents a key constraint for patients with advanced disease, where minimally invasive tissue biopsy typically returns small samples. In Part 1 of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Penault-Llorca, Frédérique, Kerr, Keith M., Garrido, Pilar, Thunnissen, Erik, Dequeker, Elisabeth, Normanno, Nicola, Patton, Simon J., Fairley, Jenni, Kapp, Joshua, de Ridder, Daniëlle, Ryška, Aleš, Moch, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review and Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485167/
https://www.ncbi.nlm.nih.gov/pubmed/35857102
http://dx.doi.org/10.1007/s00428-022-03343-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485167/
https://www.ncbi.nlm.nih.gov/pubmed/35857102
http://dx.doi.org/10.1007/s00428-022-03343-2

Ejemplares similares